General Information of Drug (ID:
DR5740) |
Drug Name |
Osilodrostat
|
Synonyms |
LCI699; 928134-65-0; LCI-699; UNII-5YL4IQ1078; CHEMBL3099695; 5YL4IQ1078; Osilodrostat;4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile; 1304733-26-3; Osilodrostat [USAN:INN]; LCI 699; Osilodrostat (USAN/INN); LCI699-NX; GTPL8310; SCHEMBL12460772; DTXSID40156570; MolPort-044-560-410; EX-A1397; ZINC72318114; s7456; BDBM50444549; AKOS027323750; DB11837; CS-6896; HY-16276; KB-78108; Z-3271; D11061; 4-[(5R)-6,7-Dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzo nitrile
|
Indication |
Cushing syndrome
[ICD11: 5A70]
|
Approved
|
[1]
|
Structure |
|
|
3D MOL is unavailable
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
227.24 |
Topological Polar Surface Area |
41.6 |
Heavy Atom Count |
17 |
Rotatable Bond Count |
1 |
Hydrogen Bond Donor Count |
0 |
Hydrogen Bond Acceptor Count |
3 |
Cross-matching ID |
- PubChem CID
- 44139752
- CAS Number
-
- TTD Drug ID
- D03AJU
- Formula
- C13H10FN3
- Canonical SMILES
- C1CC2=CN=CN2[C@H]1C3=C(C=C(C=C3)C#N)F
- InChI
- InChI=1S/C13H10FN3/c14-12-5-9(6-15)1-3-11(12)13-4-2-10-7-16-8-17(10)13/h1,3,5,7-8,13H,2,4H2/t13-/m1/s1
- InChIKey
- USUZGMWDZDXMDG-CYBMUJFWSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.